The guideline development process - an overview for stakeholders, the public and the NHS (third edition)
This booklet summarises the process used for developing NICE clinical guidelines from April 2007 onwards, including:
• how organisations can register as stakeholders
• the stages when registered stakeholders can contribute to the development of a guideline.
The section on topic selection refers to new criteria that were introduced in 2007.
![]() |
The guideline development process - an overview for stakeholders, the public and the NHS (third edition)
25 April 2007 (174.46 Kb 50 sec) |
This page was last updated: 30 March 2010
-
CG71 Familial hypercholesterolaemia: review proposal (PDF 282 KB)
-
Familial hypercholesterolaemia: review decision (PDF 153 KB)
-
Familial hypercholesterolaemia: draft consultation comments 1 (PDF 255 KB)
-
Familial hypercholesterolaemia: draft consultation comments 2 (PDF 264 KB)
-
-
Familial hypercholesterolaemia: GDG minutes 23 June 2008 (PDF 70 KB)
-
Familial hypercholesterolaemia: GDG minutes 2 May 2008 (PDF 76 KB)
-
Familial hypercholesterolaemia: GDG minutes 11 January 2008 (PDF 78 KB)
-
Familial hypercholesterolaemia: Full guideline (PDF 1.43 MB)
-
-
-
-
-
-
-
-
-
Familial hypercholesterolaemia: Comments proforma (MSWord 41 KB)
-
-
-
-
-
Familial Hypercholesterolaemia: Draft Scope, comments form (MSWord 47 KB)
-